Home Newsfeeds Reneo Pharmaceuticals Q2 EPS $(0.50) Down From $(0.43) YoY

Reneo Pharmaceuticals Q2 EPS $(0.50) Down From $(0.43) YoY

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2022

1 minute read

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.

Taiwan Semiconductor Urges Government To Boost Domestic Chip Gear, Material Making Position

By Anusuya Lahiri

March 30, 11:22 AM

Taiwan Semiconductor Manufacturing Company Ltd (NYSE: TSM) Chair Mark Liu called on the island to produce more equipment essential to advanced chipmaking.

AMAT

Deutsche Bank Maintains Buy on Lennox International, Lowers Price Target to $292

By Benzinga Newsdesk

July 13, 11:11 AM

Deutsche Bank analyst Nicole Deblase maintains Lennox International (NYSE:LII) with a Buy and lowers the price target from $335 to $292.

LII

News

Millicom (Tigo) Signs FTTH Wholesale Network Agreement With ETB In Bogota

By Benzinga Newsdesk

July 18, 7:07 AM

Millicom announces that its operation in Colombia (“Tigo Colombia”) has entered into a wholesale network access agreement with Empresa de Telecomunicaciones de Bogota (“ETB”). Under the terms of

TIGO